HEILMITTELWERBEGESETZ 2010 PDF

Tausida Carolin Kemmner Clifford Chance. In principle, the above rules with respect to the offering and granting of gifts and other benefits to healthcare professionals also apply to medical institutions. Opposition to these procedures is possible as well as an appeal to the administrative courts Verwaltungsgericht against the decisions of medical associations and associations of statutory health insurance registered doctors. The number of doctors and nurses per 1, inhabitants is high but fewer medical professionals are graduating, leading to a recruitment issue. Moreover, it is possible that competitors will contact enforcement functions to initiate an investigation in addition to seeking incentive relief regarding deviant behaviour.

Author:Najora Kelmaran
Country:Albania
Language:English (Spanish)
Genre:Medical
Published (Last):7 July 2010
Pages:463
PDF File Size:11.79 Mb
ePub File Size:14.62 Mb
ISBN:558-7-13278-555-3
Downloads:72474
Price:Free* [*Free Regsitration Required]
Uploader:Faudal



Home Practice area Pharmaceutical Advertising Germany. When advertising a product to consumers, comparisons with other medicinal products are not permitted. Developments in Pharmaceutical Advertising. Distribution and marketing of drugs in Germany: overview In each case, providing information to the readers should be the main purpose of such press releases and any advertising would only be considered as an unavoidable side effect of the publication. The newly introduced Section 2 SGB V prohibits special benefits fees or other financial benefits in connection with the prescription of medical aids, prescription-only drugs, medical products similar to drugs, dressing materials and enteral feeding.

Germany ranks lower than other European countries on innovation, despite its pioneering successes in the s and heavy investment by companies, particularly big pharma. The intentional breach of the regulations of the HWG on misleading advertising constitutes a criminal offence punishable by an imprisonment for a term of up to one year or by a fine. Pharma analyst Anne-Charlotte Honore, writes: Back to top of page Biotech There are biotech clusters in Munich, Heidelberg and Cologne, and companies in this sector have had government support, although government regulations, for example on the use of stem cells, remain restrictive.

If so, what restrictions would apply? Articles in scientific journals which comply with the conditions outlined in question 2. The aforementioned lump sums can be multiplied by up to 2. Back to top of page Overview Population: They generally seek injunctive relief to stop advertisements violating their rights on the basis of the UWG. Subscribe to our email news alerts.

Even if there is no requirement for prior approval in all cases, can the authorities require this in some circumstances? Otherwise, the comparison may be misleading and, therefore, unfair under the rules of the German Act against Unfair Competition.

What are the restrictions that are imposed on relationship with patient organisations? Distribution and marketing of drugs in Germany: overview Practical Law Career advice No results were found. The recession hit Germany hard at first, but it recovered quickly due to fiscal discipline, rebounding manufacturing exports and policies to maintain low unemployment.

It can also be used as a diagnosis tool. Pursuant to Section 11 HWG, an advertisement heilmittelserbegesetz to the general public i. The first reporting period was the calendar year Furthermore, German criminal law and the FSA-Code of Conduct Healthcare Professionals generally prohibit the provision and acceptance of any kind of benefits with respect to physicians that are granted in the context of their work, especially as heillmittelwerbegesetz for carrying out purchasing or prescription decisions.

Furthermore, a German court decided that PMS-Studies are only permissible provided that pharmaceutical companies perform such studies in strict compliance with the principle of non-intervention, i. The organisation of tours or programmes for spouses or other accompanying persons is not permissible for the same reasons.

Can and, in practice, do, the heilmittelwerbegewetz authorities investigate matters drawn to their attention that may constitute a breach of both the law and any relevant code and are already being assessed by any self-regulatory body?

It is, however, acknowledged that a pharmaceutical company may reimburse conference fees, and reasonable travel and accommodation costs. What regulatory authority is responsible for supervising distribution activities?

Accordingly, the jurisprudence considered a packaged deal consisting of the heilmittelwrebegesetz of medicines and the purchase of an additional asset to an extraordinarily reduced price here: Prescription drugs Under section 43 3 of the Medical Products Act Arzneimittelgesetz AMGmedicinal products can only be dispensed by pharmacies on prescription.

The perceived level of added clinical benefits as price driver is also being applied in other markets, such as France and Austria. As explained above in further detail, it extended criminal liability for corruptive practices to private practitioners.

Finished medicinal products are not intermediate products intended for further processing by a manufacturer. Global Legal Group Ltd. Patients are not as involved in the process of accessing information or requesting particular drugs, with the exception of the MS association, for which inVentiv Health Communications Germany Freiberg built a moderated forum that has successfully furthered its purposes as an activist patient group.

According to the new Section 15a FSA-Code of Conduct, member companies may only provide healthcare professionals with:. Country report: The healthcare market in Germany Accordingly, courts have interpreted the legislation in this way.

These high income workers and selfemployed professionals choose to pay a tax and opt out of the public system, taking out private policies. Germany does not have one single economic centre, but as a federation it has several industrial centres, such as Stuttgart, Munich, Frankfurt, Hamburg, Leipzig and Bremen.

In such cases, a court might argue that it is obvious for the end-consumer that only this specific medicinal product on the market can treat the disease and that this disease awareness campaign is therefore non-permissible as it circumvents the general prohibition on advertising for heilmittelwegbegesetz medicines to the general public. The question of whether the medicinal product may be distributed in another country based on the German authorisation must be answered based on the law of that country.

TOP Related Posts.

C2026 DATASHEET PDF

Heilmittelwerbegesetz unbedingt reformieren

Mokinos Depending on the market shares package deals may also be critical under competition law-related aspects. Only informational and educational materials or items of medical utility and samples may be provided. In fact, the same general principles as set forth above apply. Please login to the form below.

ARCHIVE ECHOUROUK PDF

Heilmittelwerbegesetz

Home Practice area Pharmaceutical Advertising Germany. When advertising a product to consumers, comparisons with other medicinal products are not permitted. Developments in Pharmaceutical Advertising. Distribution and marketing of drugs in Germany: overview In each case, providing information to the readers should be the main purpose of such press releases and any advertising would only be considered as an unavoidable side effect of the publication. The newly introduced Section 2 SGB V prohibits special benefits fees or other financial benefits in connection with the prescription of medical aids, prescription-only drugs, medical products similar to drugs, dressing materials and enteral feeding. Germany ranks lower than other European countries on innovation, despite its pioneering successes in the s and heavy investment by companies, particularly big pharma. The intentional breach of the regulations of the HWG on misleading advertising constitutes a criminal offence punishable by an imprisonment for a term of up to one year or by a fine.

Related Articles